BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 25539374)

  • 1. Global harmonization of quality assurance naming conventions in radiation therapy clinical trials.
    Melidis C; Bosch WR; Izewska J; Fidarova E; Zubizarreta E; Ulin K; Ishikura S; Followill D; Galvin J; Haworth A; Besuijen D; Clark CH; Miles E; Aird E; Weber DC; Hurkmans CW; Verellen D
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1242-9. PubMed ID: 25539374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours - a clinical physics perspective.
    Lambrecht M; Melidis C; Sonke JJ; Adebahr S; Boellaard R; Verheij M; Guckenberger M; Nestle U; Hurkmans C
    Radiat Oncol; 2016 Jan; 11():7. PubMed ID: 26791788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of remote 3-dimensional image guided radiation therapy quality assurance for radiation therapy oncology group clinical trials.
    Cui Y; Galvin JM; Parker W; Breen S; Yin FF; Cai J; Papiez LS; Li XA; Bednarz G; Chen W; Xiao Y
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):271-7. PubMed ID: 22541964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines.
    Mir R; Kelly SM; Xiao Y; Moore A; Clark CH; Clementel E; Corning C; Ebert M; Hoskin P; Hurkmans CW; Ishikura S; Kristensen I; Kry SF; Lehmann J; Michalski JM; Monti AF; Nakamura M; Thompson K; Yang H; Zubizarreta E; Andratschke N; Miles E
    Radiother Oncol; 2020 Sep; 150():30-39. PubMed ID: 32504762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of deviations in target volume delineation - Time for a new RTQA approach?
    Cox S; Cleves A; Clementel E; Miles E; Staffurth J; Gwynne S
    Radiother Oncol; 2019 Aug; 137():1-8. PubMed ID: 31039468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detailed review and analysis of complex radiotherapy clinical trial planning data: evaluation and initial experience with the SWAN software system.
    Ebert MA; Haworth A; Kearvell R; Hooton B; Coleman R; Spry N; Bydder S; Joseph D
    Radiother Oncol; 2008 Feb; 86(2):200-10. PubMed ID: 18077034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful implementation of image-guided radiation therapy quality assurance in the Trans Tasman Radiation Oncology Group 08.01 PROFIT Study.
    Middleton M; Frantzis J; Healy B; Jones M; Murry R; Kron T; Plank A; Catton C; Martin J
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1576-81. PubMed ID: 21074334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization and quality assurance of an image-guided radiation therapy system for intensity-modulated radiation therapy radiotherapy.
    Tsai JS; Micaily B; Miyamoto C
    Med Dosim; 2012; 37(3):321-33. PubMed ID: 22417899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Credentialing of radiotherapy centres for a clinical trial of adaptive radiotherapy for bladder cancer (TROG 10.01).
    Kron T; Pham D; Roxby P; Rolfo A; Foroudi F
    Radiother Oncol; 2012 Jun; 103(3):293-8. PubMed ID: 22483676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy practice for paediatric brain tumours across Europe and quality assurance initiatives: Current situation, international survey and future perspectives.
    de Rojas T; Clementel E; Giralt J; Cruz O; Boterberg T; Kortmann RD; Gaze MN; Moreno L; Janssens GO;
    Eur J Cancer; 2019 Jun; 114():36-46. PubMed ID: 31035085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality assurance of radiotherapy in the ongoing EORTC 1420 "Best of" trial for early stage oropharyngeal, supraglottic and hypopharyngeal carcinoma: results of the benchmark case procedure.
    Stelmes JJ; Vu E; Grégoire V; Simon C; Clementel E; Kazmierska J; Grant W; Ozsahin M; Tomsej M; Vieillevigne L; Fortpied C; Hurkmans EC; Branquinho A; Andratschke N; Zimmermann F; Weber DC
    Radiat Oncol; 2021 May; 16(1):81. PubMed ID: 33933118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality assurance of radiotherapy in cancer treatment: toward improvement of patient safety and quality of care.
    Ishikura S
    Jpn J Clin Oncol; 2008 Nov; 38(11):723-9. PubMed ID: 18952706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Multicentre quality assurance of intensity-modulated radiation therapy planning: beware the benchmarker.
    Williams MJ; Bailey MJ; Forstner D; Metcalfe PE
    J Med Imaging Radiat Oncol; 2008 Jun; 52(3):303. PubMed ID: 18477127
    [No Abstract]   [Full Text] [Related]  

  • 14. Redesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials--report of the National Cancer Institute Work Group on Radiotherapy Quality Assurance.
    Bekelman JE; Deye JA; Vikram B; Bentzen SM; Bruner D; Curran WJ; Dignam J; Efstathiou JA; FitzGerald TJ; Hurkmans C; Ibbott GS; Lee JJ; Merchant TE; Michalski J; Palta JR; Simon R; Ten Haken RK; Timmerman R; Tunis S; Coleman CN; Purdy J
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):782-90. PubMed ID: 22425219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External dosimetry audit for quality assurance of carbon-ion radiation therapy clinical trials.
    Mizuno H; Fukumura A; Kanematsu N; Yonai S; Shirai T; Yusa K; Yanou T; Suga M; Mizota M; Minohara S; Kanai T; Kamada T
    J Appl Clin Med Phys; 2019 Jan; 20(1):31-36. PubMed ID: 30387294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancer.
    Sydes MR; Stephens RJ; Moore AR; Aird EG; Bidmead AM; Fallowfield LJ; Graham J; Griffiths S; Mayles WP; McGuire A; Stanley S; Warrington AP; Dearnaley DP;
    Radiother Oncol; 2004 Aug; 72(2):199-211. PubMed ID: 15297138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Feasibility of Quality Assurance in the TOPGEAR International Phase 3 Clinical Trial of Neoadjuvant Chemoradiation Therapy for Gastric Cancer (an Intergroup Trial of the AGITG/TROG/NHMRC CTC/EORTC/CCTG).
    Lukovic J; Moore AJ; Lee MT; Willis D; Ahmed S; Akra M; Hortobagyi E; Kron T; Lim Joon D; Liu A; Ryan J; Thomas M; Wall K; Ward I; Wiltshire KL; O'Callaghan CJ; Wong RKS; Ringash JG; Haustermans K; Leong T
    Int J Radiat Oncol Biol Phys; 2023 Dec; 117(5):1096-1106. PubMed ID: 37393022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A semi-automated tool for treatment plan-quality evaluation and clinical trial quality assurance.
    Wang J; Chen W; Studenski M; Cui Y; Lee AJ; Xiao Y
    Phys Med Biol; 2013 Jul; 58(13):N181-7. PubMed ID: 23756538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dummy run of quality assurance program in a phase 3 randomized trial investigating the role of internal mammary lymph node irradiation in breast cancer patients: Korean Radiation Oncology Group 08-06 study.
    Chung Y; Kim JW; Shin KH; Kim SS; Ahn SJ; Park W; Lee HS; Kim DW; Lee KC; Suh HS; Kim JH; Shin HS; Kim YB; Suh CO
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):419-26. PubMed ID: 25636764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial experience with quality assurance of multi-institutional 3D radiotherapy clinical trials. A brief report.
    Purdy JA; Harms WB; Michalski J; Bosch WR
    Strahlenther Onkol; 1998 Oct; 174 Suppl 2():40-2. PubMed ID: 9810337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.